DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prandin (Repaglinide) - Hydronephrosis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hydronephrosis (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prandin (Repaglinide) where reactions include hydronephrosis. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Prandin side effects in female

Reported by a physician from Korea, Republic of on 2012-03-20

Patient: female, weighing 46.1 kg (101.4 pounds)

Reactions: Hydronephrosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prandin
    Dosage: 6 mg, bid
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2012-01-22

Sandimmune
    Dosage: 175 mg, qd
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2012-01-17

Certican
    Dosage: 1.5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-02-17

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017